Viewing Study NCT00762892


Ignite Creation Date: 2025-12-24 @ 3:31 PM
Ignite Modification Date: 2025-12-27 @ 7:04 PM
Study NCT ID: NCT00762892
Status: COMPLETED
Last Update Posted: 2015-01-05
First Post: 2008-09-26
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients
Sponsor: The University of Texas Health Science Center, Houston
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-01
Start Date Type: None
Primary Completion Date: 2012-12
Primary Completion Date Type: ACTUAL
Completion Date: 2013-01
Completion Date Type: ACTUAL
First Submit Date: 2008-09-26
First Submit QC Date: None
Study First Post Date: 2008-09-30
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2014-12-19
Results First Submit QC Date: None
Results First Post Date: 2015-01-05
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-12-19
Last Update Post Date: 2015-01-05
Last Update Post Date Type: ESTIMATED